leisure time -WSS

leisure time

author：comprehensive 2025-09-04 09:25:44 Page View：15144

AI skin cancer detector, dermasensor. -- health tech coverage from STAT — Around 5 million skin cancers are diagnosed each year in the United States. Skin cancer is common, but it’s also not that deadly when caught early. Courtesy DermaSensor

The Food and Drug Administration cleared an AI-powered device for detecting skin cancer on Wednesday, giving primary care physicians a new way to evaluate troubling skin spots.

Around 5 million skin cancers are diagnosed each year in the United States. Skin cancer is common, but most types are not that deadly when caught early.

The device, developed by a small company called DermaSensor, is handheld and uses light to examine suspicious moles on a cellular level. It will be marketed specifically for primary care physicians to use in routine check-ups in patients aged 40 and above.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： First U.S. drug developed to treat liver disease MASH is approved
Next article： Apple is now the first public company to be valued at $3 trillion

explore

Tori Bowie and the unacceptable rates of Black maternal death

AlastairGrant/APThehorrorstoriesofBlackwomendyingorcomingclosetodeathinchildbirthneverseemtostopcomi

In boost for rare disease push, AstraZeneca to buy Amolyt Pharma

AlastairGrant/APLONDON— AstraZenecasaidThursdayitwouldpurchasetheFrenchfirmAmolytPharmainadealworthu

How to save PrEP access — and even expand it

UndertheAffordableCareAct,healthinsurersarerequiredtocoverallcostsassociatedwithpreventivecare—inclu

FDA approves Moderna’s RSV vaccine, its second licensed product

TheFDAhasapprovedModerna’sRSVvaccineforolderadults.ModernaTheFoodandDrugAdministrationonFridayapprov

leisure time

knowledge

explore

FDA approves Moderna’s RSV vaccine, its second licensed product